The Aurum Institute is an internationally recognised but proudly African, public-benefit specialist research and implementation organisation with over 18 years’ experience in leading the response, treatment and research efforts to eradicate the TB and HIV pandemics. It has been working alongside government, the mining industry, among NGO’s and in communities, to better understand global health challenges to provide real solutions.
The institute’s aim is to improve the health of people and communities by strengthening existing health care systems, constantly innovating to improve methods, and conducting research to determine the best ways to eliminate TB and HIV.
Over the past 18 years Aurum has grown from small beginnings and currently employs about 1200 staff, has an annual operating budget of $55 million and has managed grants in excess of $200 million that focus on TB and HIV research and health programmes.
The Aurum Institute has a for-profit, wholly owned subsidiary company – INNOVA – that generates funds to be used to support Aurum’s core costs. It has recently established Aurum Institute USA, based in Washington DC, to focus on fund raising, employing US based personnel, and grants management. Aurum is also exploring establishing other offshore and in-country offices where there is a compelling Global Health case to do so.